Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer

Figure 5

Gypenosides inhibited the proliferation and induced apoptosis of bladder cancer cells. (a) Cells were treated with gypenosides for 48 h, and a CCK8 assay was employed to assess viability. Errors bars show the standard deviation (SD) of the mean of three independent tests. (b) Five hundred cells were plated in a 6-well plate for eight days and treated with gypenosides or DMSO. (c) Quantification of colony formation assays. Student’s -test, Error bars show the SD of the mean for three replicate wells, . (d) Flow cytometry was employed to analyze the staining of propidium iodide (PI) and annexin V in control or gypenoside-treated cells. (e) Quantification of the apoptosis ratio. Student’s -test, are given, . (f) Western blot experiments indicating the expression levels of Bax, Bcl2, and Caspase 9 in the cells treated with DMSO or gypenosides. (g) The Bax/Bcl2 ratio was quantified by ImageJ. Student’s -test, are given, . (h and i) The relative proportion of cell cycle phases in T24 cells treated with DMSO or gypenosides. are given, n.s., no significant variation, . (j and k) The relative proportion of cell cycle phases in 5637 cells treated with DMSO or gypenosides. are given, n.s., no significant variation, . (l) Immunoblot analysis of the expression of CDK2, CDK4, and Cyclin D1 quantified by ImageJ.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)